OpenVSafe by OpenVAERS
Search V-safe

E67-33323-68796

3 vaccinations 9 coded responses 34 check-ins 9 free-text entries 0 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
980 / WA
Registered
2020-12-19
Relationship
Self
Race
Asian
Ethnicity
Not Hispanic or Latino
Registered dependents
2NR-19235-85550 Child or adolescent in my care · Male · 2021-11-13
XM2-13814-01254 Child or adolescent in my care · Male · 2021-11-13

Timeline

  1. 2020-12-19
    Registered in v-safe
  2. 2020-12-19
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-19
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  5. 2020-12-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2020-12-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2020-12-26
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-07
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-08
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  11. 2021-01-09
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy, Swelling — Feeling: Good · Site: Pain
    Free text: Enlarged left Supraclavicular lymph node with surrounding swelling (injection was on left side) . Sx is mild.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  12. 2021-01-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Left supraclavilar swelling ipsalateral to injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-01-11
    Survey response — days 1–6 daily, dose 2
    MedDRA: Swelling — Feeling: Good
    Free text: Left supraclavicular swelling - mild
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-01-12
    Survey response — days 1–6 daily, dose 2
    MedDRA: Swelling — Feeling: Good
    Free text: Left supraclavicular swelling- improving. Mild.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-13
    Survey response — days 1–6 daily, dose 2
    MedDRA: Swelling — Feeling: Good
    Free text: Left supraclavicular swelling improving.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-01-14
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-21
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-01-28
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-02-04
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-11
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-18
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-08
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-08
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-10-07
    Dose 3 — Pfizer-BioNTech
  25. 2021-10-09
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain — Feeling: Good · Site: Pain
    Free text: Tender ipsalateral lymph nodes
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-10
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Tender enlarged ipsalateral supraclavicular lymph nodes
    MedDRA releases: 2024-11 · check-in free text available
  27. 2021-10-11
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy, Tenderness — Feeling: Good
    Free text: Swelling of supraclavicular lymph nodes since injection, but has started to decrease and is not tender anymore
    MedDRA releases: 2024-11 · check-in free text available
  28. 2021-10-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  29. 2021-10-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  30. 2021-10-14
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  31. 2021-10-21
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-10-28
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-11-04
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  34. 2021-11-11
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  35. 2021-11-18
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  36. 2022-01-06
    Survey response — 3 months, dose 3
    MedDRA: Fatigue, Respiratory tract congestion, SARS-CoV-2 test negative — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Congestion, fatigue . Covid test was negative.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2022-04-07
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  38. 2022-10-07
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12020-12-19Pfizer-BioNTech
22021-01-07Pfizer-BioNTech
32021-10-07Pfizer-BioNTech No

Free text

Release 1 — days 1–6 daily, dose 2

2021-01-09

Systemic reaction (other): Enlarged left Supraclavicular lymph node with surrounding swelling (injection was on left side) . Sx is mild.

2021-01-10

Systemic reaction (other): Left supraclavilar swelling ipsalateral to injection site

2021-01-11

Systemic reaction (other): Left supraclavicular swelling - mild

2021-01-12

Systemic reaction (other): Left supraclavicular swelling- improving. Mild.

2021-01-13

Systemic reaction (other): Left supraclavicular swelling improving.

Release 10 — days 1–6 daily, dose 3

2021-10-09

Systemic reaction (other): Tender ipsalateral lymph nodes

2021-10-10

Systemic reaction (other): Tender enlarged ipsalateral supraclavicular lymph nodes

2021-10-11

Systemic reaction (other): Swelling of supraclavicular lymph nodes since injection, but has started to decrease and is not tender anymore

Release 10 — 3 months, dose 3

2022-01-06

Symptoms: Congestion, fatigue . Covid test was negative.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDFatigue · · ✓
SDRespiratory tract congestion · · ✓
SDSARS-CoV-2 test negative · · ✓
SROInjection site swelling ○ ○ ○
SROLymph node pain · · ✓
SROLymphadenopathy ✓ ✓ ✓
SROSwelling ✓ ✓ ✓
SROTenderness · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release